Business is business. Maybe it's about making a difference in the world of consumers but mostly, it's about making money. I get that -- and if I owned my own company and offered some sort of product, surely my goal would be to reap a financial reward. And if I wanted to increase my reward, I guess I would consider new markets, new advertising, and new techniques for hauling in loads of cash.

So I see what's going on with the new Camel No. 9 cigarettes, in their hot-pink fuscia and minty-teal green packages with the slogan Light and Luscious. I understand this brand is targeting female smokers with enticing wording that Camel maker R.J. Reynolds executives say is meant to suggest dressed to the nines, putting on your best. I even get that it's a pretty savvy strategy. But somehow, it all seems so wrong.

In a world where more women die of lung cancer than breast cancer -- by a large margin -- how can anyone, even business people whose sights are set on profits, feel OK with the decision to encourage women to smoke?

Think about these passages that just recently published in a New York Times article:

Wall Street analysts praise the introduction of Camel No. 9, in regular and menthol flavors, as a further step by the R. J. Reynolds, a unit of Reynolds American, toward a new marketing strategy. The goal is to refocus on the biggest, most popular -- and most profitable -- brands, which include Kool as well as Camel.

"What we're about is giving adult smokers a choice," says one executive, "with products we believe are more appealing than existing products." The introduction of Camel No. 9 is part of plans to "focus on products that are 'wow,' " she added, "that add fun and excitement to the category."

Fun and excitement? Believe me, there's nothing fun and exciting about cancer. Now if I could only package that truth and market it to the world. I suspect I'd be a rich woman -- and I don't mean financially.

I read something yesterday written by a reporter who is fed up with the treatment of celebrities in the media. She is tired of the spectacular headlines about babies born to celebrities and adoptions by celebrities and every-day struggles of celebrities that blur the fact that these same things happen to real people -- non-celebrities -- and are rarely covered in the news. Sure, some of the celebrity coverage may lead to awareness. The fact that Angelina Jolie and Brad Pitt are talking of adopting another child may encourage others in the world to reach out to homeless children. But where is the news about hoards of women who gather and walk in search of a cure for breast cancer? And why was the coming-out announcement by former In Sync band member Lance Bass the top news story on CNN the other day? Because people pay attention to announcements like these -- and however disturbing it may be -- is causes a stir. And perhaps, like this reporter says, others will gain some strength from Bass and will tackle their own sexual orientation more openly.

A news story caught my attention the other night. Not because of the news -- initially -- but because of the names that were thrown around. Names like Kelly Ripa and Lindsey Lohan and Molly Shannon -- names that were not all that important in the scheme of the story I would eventually hear. But they hooked me. And then I learned about a great event that took place last Saturday in an effort to raise funds for ovarian cancer.

Super Saturday is a day-long summer fundraising event for the entire family -- created by Donna Karan and sponsored by In Style magazine. The day features a designer garage sale with more than 200 designers, a raffle, a carnival for kids, food and refreshments, and goodie bags. All proceeds -- from ticket sales and the garage sale and raffles -- go to the Ovarian Cancer Research Fund. Last year's event raised $2 million. And this year, the tally for the ninth annual event that took place in the Hamptons, is yet to be reported. What was reported is that the event was a success -- and celebrities were in attendance. And that made me pay attention.

Right here in Gainesville, Florida -- at the University of Florida to be exact -- the vaccine for cervical cancer is now available for college students. This vaccine -- called Gardasil -- could prevent women from contracting the human papillomavirus (HPV) which can cause cervical cancer and genital warts. Almost 30 of the more than 100 different strains of HPV are sexually transmitted -- and sometime in their lives, 50 percent of sexually active men and women will contract genital HPV infection. Many will not know they have it and will spread it unknowingly to sexual partners. Protection can come in the form of Gardasil which is approved for use in women between the ages of 9 and 26.

Women who are not sexually active are the best candidates for this vaccine because it is clear that they have not yet been infected. The vaccine is not effective for women who already are infected with HPV. And those who don't know if they are infected can determine if they have HPV through a routine Pap smear. If they do not have HPV, the vaccine is indicated. Once the vaccine is indicated, it is delivered in three separate doses over a six-month period of time. Each dose costs $120 -- which may discourage students from this option.

About 9,700 women in the United States will develop cervical cancer in 2006 and this cancer will kill 3,700 of these women. This vaccine -- if received well by young women who can afford it -- should prove a breakthrough in cancer research and prevention.